Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab′) 2
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Autoimmune encephalomyelitis may be ameliorated experimentally by enhancing NK cell-mediated elimination of activated autoreactive T cells through a mutation that interrupts the interaction between Qa-1 b and CD94/NKG2A. Here we evaluate the ability of an anti-NKG2A F(ab′) 2 Ab to enhance elimination of autoreactive T cells and reduce experimental autoimmune encephalomyelitis (EAE). Anti-NKG2A F(ab′) 2 treatment diminishes progression of both myelin oligodendrocyte glycoprotein (MOG)-induced EAE in intact C57BL/6 mice and after adoptive transfer of disease-causing T cells. Analyses of the underlying mechanism revealed that administration of anti-NKG2A F(ab′) 2 Ab reduces CD4 + T recall responses to MOG and skews the proportion of IL-17- and IFNγ-producing CD4 + T cells toward the protective IL-4- and IL-10-secreting CD4 + T cell subpopulations. CD94/NKG2A-dependent inhibition of inflammatory damage to spinal cord is associated with decreased infiltration of T cells and reduced microglia activation in the central nervous system. Because anti-NKG2A F(ab′) 2 treatment had no detectable effect on the numbers or activity of T and B lymphocytes and NK cells in peripheral lymphoid tissues, this anti-NKG2A-based approach may represent a safe and effective therapy for this CNS disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Jäger, A., Dardalhon, V., Sobel, R. A., Bettelli, E., & Kuchroo, V. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901906 · Cited by 783
Cited by
The Role of Microglia and Macrophages in CNS Homeostasis, Autoimmunity, and Cancer
Yin, J., Valin, K. L., Dixon, M. L., & Leavenworth, J. W. (2017) · Journal of Immunology Research · doi:10.1155/2017/5150678 · Cited by 202
“Interestingly, a recent study using the parabiosis model combined with highly efficient permanent labeling of blood monocytes has elegantly revealed that circulating monocytes invade the inflamed CNS during EAE pathogenesis and have an essential role in promoting disease progression [80].”
InfluentialSelf-citationLi, F., Wei, H., Wei, H., Gao, Y., Xu, L., Yin, W., Sun, R., & Tian, Z. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.039 · Cited by 164
Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE
Van Kaer, L., Postoak, J. L., Wang, C., Yang, G., & Wu, L. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0221-5 · Cited by 148
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis
Laroni, A., Armentani, E., Kerlero de Rosbo, N., Ivaldi, F., Marcenaro, E., Sivori, S., Gandhi, R., Weiner, H. L., Moretta, A., Mancardi, G. L., et al. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.04.003 · Cited by 112
Metadata
- Authors
- Leavenworth, J. W., Schellack, C., Kim, H.-J., Lu, L., Spee, P., & Cantor, H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-01-21
- Volume
- 107
- Issue
- 6
- Pages
- 2562-2567
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2002979752
- Cited by
- 71
- References
- 2
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab′) 2. https://app.cochat.ai/papers/10.1073/pnas.0914732107
- The paper
- Leavenworth, J. W., Schellack, C., Kim, H.-J., Lu, L., Spee, P., & Cantor, H. (2010). Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab′) 2. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0914732107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.